Explore by Your Process
The pioneer in virus filtration for plasma-derived products
Since 1989, Planova™ virus removal filters have been trusted by various pharmaceutical companies in ensuring viral safety of their plasma-derived products, such as immunoglobulins, coagulation factors, alpha-1-antitrypsin, c1inhibitors, and many others. Explore this page to find resources that may help you in improving the safety and efficiency of your plasma-derived product manufacturing processes.
Featured products and services
Planova™ S20N Virus Removal Filters
Planova™ 15N, 20N & 35N Virus Removal Filters
The Pioneer Virus Filter with Proven Reliability Since 1989
Removal of small viruses (parvovirus) from IgG solution by virus removal filter Planova™ 20N
Hongo, T., et al.
Asahi Kasei Medical Co., Ltd. and Yamaguchi University
Journal of Membrane Science 278: 3-9
Implementation of a 20-nm pore-size filter in the plasma-derived Factor VIII manufacturing process
Furuya, K., et al.
Japanese Red Cross Plasma Fractionation Center
Vox Sanguinis 91: 119-125
Viral safety of C1-inhibitor NF
Terpstra, F. G., et al.
Sanquin Research and Landsteiner Laboratory of the Academic Medical Center of the University of Amsterdam and Sanquin Plasma Products
Biologicals 35: 173-181
You need to login to download the files.
The Application of Planova™ BioEX in the Plasma-Derived IVIG Manufacturing Process
Yang HuHu, Engineer, Shandong Taibang Biological Products, Co., Ltd.
16th Planova™ Workshop
Nov 7, 2013 to Nov 8, 2013 Rome
Effective and Robust Virus Filtration
Nathan J. Roth, Senior Director & Head Global Pathogen Safety, CSL Behring
19th Planova™ Workshop
Sep 22, 2016 to Sep 23, 2016 Philadelphia
Understanding Planova™ Virus Filtration and Designing Robust Virus Filtration Processes
Tomoko Hongo-Hirasaki, Senior Scientist, Group Manager of Evaluation and Analysis, Asahi Kasei Medical
20th Planova™ Workshop
Nov 9, 2017 to Nov 10, 2017 Prague